Evaluation of a double-target therapeutic in preclinical models of Parkinson's disease

被引：0
|
作者：
Sanz, F. J.
Solana-Manrique, C.
Masia, E.
Vicent, M. J.
Paricio, N.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
532
引用
收藏
页码：S233 / S233
页数：1
相关论文
共 50 条
  • [31] Gut microbiota: a potential therapeutic target for Parkinson's disease
    José Fidel Baizabal-Carvallo
    Neural Regeneration Research, 2021, 16 (02) : 287 - 288
  • [32] The Epigenetics Changes in Parkinson's Disease: a Novel Therapeutic Target
    Yuan, Ti-Fei
    Li, Jiang
    Shan, Chun-Lei
    CNS NEUROSCIENCE & THERAPEUTICS, 2014, 20 (04) : 299 - 300
  • [33] Potassium Channels: A Potential Therapeutic Target for Parkinson's Disease
    Chen, Xiaoyan
    Xue, Bao
    Wang, Jun
    Liu, Haixia
    Shi, Limin
    Xie, Junxia
    NEUROSCIENCE BULLETIN, 2018, 34 (02) : 341 - 348
  • [34] Potassium Channels: A Potential Therapeutic Target for Parkinson's Disease
    Xiaoyan Chen
    Bao Xue
    Jun Wang
    Haixia Liu
    Limin Shi
    Junxia Xie
    Neuroscience Bulletin, 2018, 34 (02) : 341 - 348
  • [35] Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease
    Zhu, Manlian
    Liu, Xia
    Ye, Yiru
    Yan, Xiumei
    Cheng, Yiwen
    Zhao, Longyou
    Chen, Feng
    Ling, Zongxin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [36] Cannabinoid receptor as a potential therapeutic target for Parkinson's Disease
    Baul, Himadri Shekhaar
    Manikandan, Ceera
    Sen, Dwaipayan
    BRAIN RESEARCH BULLETIN, 2019, 146 : 244 - 252
  • [37] Neuroinflammation in Parkinson’s disease and its potential as therapeutic target
    Qinqin Wang
    Yingjun Liu
    Jiawei Zhou
    Translational Neurodegeneration, 4
  • [38] Pharmacological chaperoning of nAChRs: A therapeutic target for Parkinson's disease
    Srinivasan, Rahul
    Henderson, Brandon J.
    Lester, Henry A.
    Richards, Christopher I.
    PHARMACOLOGICAL RESEARCH, 2014, 83 : 20 - 29
  • [39] The gut microbiota: A novel therapeutic target in Parkinson's disease?
    Lubomski, Michal
    Davis, Ryan L.
    Sue, Carolyn M.
    PARKINSONISM & RELATED DISORDERS, 2019, 66 : 265 - 266
  • [40] GPR55: A therapeutic target for Parkinson's disease?
    Celorrio, Marta
    Rojo-Bustamante, Estefania
    Fernandez-Suarez, Diana
    Saez, Elena
    Estella-Hermoso de Mendoza, Ander
    Mueller, Christa E.
    Ramirez, Maria J.
    Oyarzabal, Julen
    Franco, Rafael
    Aymerich, Maria S.
    NEUROPHARMACOLOGY, 2017, 125 : 319 - 332
12345